Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Parcella KE"'
Autor:
Zhuo X; a Departments of Pharmaceutical Candidate Optimisation , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA and., Wang YZ; a Departments of Pharmaceutical Candidate Optimisation , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA and., Yeung KS; b Discovery Chemistry and Molecular Technologies , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA., Zhu J; b Discovery Chemistry and Molecular Technologies , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA., Huang XS; a Departments of Pharmaceutical Candidate Optimisation , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA and., Parcella KE; b Discovery Chemistry and Molecular Technologies , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA., Eastman KJ; b Discovery Chemistry and Molecular Technologies , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA., Kadow JF; b Discovery Chemistry and Molecular Technologies , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA., Meanwell NA; b Discovery Chemistry and Molecular Technologies , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA., Shu YZ; a Departments of Pharmaceutical Candidate Optimisation , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA and., Johnson BM; a Departments of Pharmaceutical Candidate Optimisation , Bristol-Myers Squibb Research and Development , Wallingford , CT , USA and.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2018 Dec; Vol. 48 (12), pp. 1215-1226. Date of Electronic Publication: 2017 Dec 12.
Autor:
Zhuo X; Bristol-Myers Squibb; xiaoliang.zhuo@bms.com., Cantone JL; Bristol-Myers Squibb;, Wang Y; Bristol-Myers Squibb;, Leet JE; Bristol-Myers Squibb;, Drexler DM; Bristol-Myers Squibb;, Yeung KS; Bristol-Myers Squibb;, Huang XS; Bristol-Myers Squibb;, Eastman KJ; Bristol-Myers Squibb;, Parcella KE; Bristol-Myers Squibb;, Mosure KW; Bristol-Myers Squibb;, Soars MG; Bristol-Myers Squibb;, Kadow JF; Bristol-Myers Squibb;, Johnson BM; Bristol-Myers Squibb Company.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2016 Aug; Vol. 44 (8), pp. 1332-1340. Date of Electronic Publication: 2016 Mar 09.
Autor:
McFadden, William M.1 (AUTHOR), Snyder, Alexa A.1 (AUTHOR), Kirby, Karen A.1,2 (AUTHOR), Tedbury, Philip R.1,2 (AUTHOR), Raj, Monika3 (AUTHOR), Wang, Zhengqiang4 (AUTHOR), Sarafianos, Stefan G.1,2 (AUTHOR) stefanos.sarafianos@emory.edu
Publikováno v:
Retrovirology. 12/22/2021, Vol. 18 Issue 1, p1-24. 24p.
Autor:
Khojasteh, S. Cyrus1 pars@gene.com, Miller, Grover P.2, Mitra, Kaushik3, Rietjens, Ivonne M. C. M.4
Publikováno v:
Drug Metabolism Reviews. Aug2018, Vol. 50 Issue 3, p221-255. 35p.
Publikováno v:
Molecular Diversity; Feb2022, Vol. 26 Issue 1, p245-264, 20p
Publikováno v:
Drug Metabolism Reviews; Aug2018, Vol. 50 Issue 3, p221-255, 35p
Autor:
Michael J. Sofia
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV) and infects approximately 75 million individuals worldwide. It is also one of the major causes of liver cancer and liver transplants. The elucidation of the HCV genome, and the deve